Wells Fargo Initiates Savara(SVRA.US) With Buy Rating, Announces Target Price $8

Futu NewsDec 21 02:31 · Ratings

Wells Fargo Initiates Coverage On Savara With Overweight Rating, Announces Price Target of $8

BenzingaDec 20 21:24 · Ratings

Savara Analyst Ratings

BenzingaDec 19 23:18 · Ratings

JMP Securities Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $9

Futu NewsDec 19 18:31 · Ratings

Savara Positioned for Success: Buy Rating Boosted by Strong BLA Progress and Market Potential for Molbreevi

TipRanksDec 19 18:25 · Ratings

Savara Initiates Rolling Submission Of Biologics License Application To FDA For MOLBREEVI In Potential Treatment Of Autoimmune Pulmonary Alveolar Proteinosis

BenzingaDec 19 05:06